Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. uri icon

authors

  • Xian, Ying
  • Webb, Laura
  • Bettger, Janet Prvu
  • Daniel Laskowitz, MD, MHS
  • Fonarow, Gregg C
  • Peterson, Eric D
  • Federspiel, Jerome J
  • Grau-Sepulveda, Maria
  • Hernandez, Adrian F
  • Schwamm, Lee H
  • Bhatt, Deepak L
  • Smith, Eric E
  • Reeves, Mathew J
  • Thomas, Laine

publication date

  • January 2016